Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 10683
MIM: 602768
HGNC: 2909
Ensembl: ENSG00000090932
Variants:
dbSNP: 10683
ClinVar: 10683
TCGA: ENSG00000090932
COSMIC: DLL3
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000090932 | ENST00000205143 | Q9NYJ7 |
| ENSG00000090932 | ENST00000596614 | M0R177 |
Expression (GTEx)
Pathways
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 34931456 | 2022 | ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China. | 3 |
| 35983951 | 2022 | DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms. | 18 |
| 34931456 | 2022 | ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China. | 3 |
| 35983951 | 2022 | DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms. | 18 |
| 33031101 | 2021 | TTF-1 and c-MYC-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for Treatment Selection. | 2 |
| 33409812 | 2021 | Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms. | 12 |
| 34107132 | 2021 | Delta-like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview. | 11 |
| 34184566 | 2021 | Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis. | 6 |
| 33031101 | 2021 | TTF-1 and c-MYC-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for Treatment Selection. | 2 |
| 33409812 | 2021 | Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms. | 12 |
| 34107132 | 2021 | Delta-like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview. | 11 |
| 34184566 | 2021 | Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis. | 6 |
| 32554516 | 2020 | A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces Antitumor Responses in Small Cell Lung Cancer. | 32 |
| 32691982 | 2020 | DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC. | 10 |
| 32554516 | 2020 | A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces Antitumor Responses in Small Cell Lung Cancer. | 32 |
Citation
Dessen P
DLL3 (delta like canonical Notch ligand 3)
Atlas Genet Cytogenet Oncol Haematol. 2007-04-01
Online version: http://atlasgeneticsoncology.org/gene/47257/dll3
